Krakchemia Statistics
Total Valuation
Krakchemia has a market cap or net worth of PLN 9.41 million. The enterprise value is 12.44 million.
Market Cap | 9.41M |
Enterprise Value | 12.44M |
Important Dates
The last earnings date was Friday, April 25, 2025.
Earnings Date | Apr 25, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Krakchemia has 9.00 million shares outstanding.
Current Share Class | 9.00M |
Shares Outstanding | 9.00M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 60.44% |
Owned by Institutions (%) | n/a |
Float | 3.56M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.21 |
PB Ratio | -0.15 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.92 |
EV / Sales | 0.28 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.11
Current Ratio | 0.11 |
Quick Ratio | 0.08 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -0.86 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -19.87% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 9.95% |
Revenue Per Employee | 1.49M |
Profits Per Employee | -449,767 |
Employee Count | 30 |
Asset Turnover | 2.36 |
Inventory Turnover | 12.45 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +329.75% in the last 52 weeks. The beta is -0.08, so Krakchemia's price volatility has been lower than the market average.
Beta (5Y) | -0.08 |
52-Week Price Change | +329.75% |
50-Day Moving Average | 1.10 |
200-Day Moving Average | 0.96 |
Relative Strength Index (RSI) | 44.04 |
Average Volume (20 Days) | 69,278 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Krakchemia had revenue of PLN 44.60 million and -13.49 million in losses. Loss per share was -1.50.
Revenue | 44.60M |
Gross Profit | 5.76M |
Operating Income | -6.02M |
Pretax Income | -13.57M |
Net Income | -13.49M |
EBITDA | -5.07M |
EBIT | -6.02M |
Loss Per Share | -1.50 |
Balance Sheet
The company has 633,000 in cash and 3.67 million in debt, giving a net cash position of -3.04 million or -0.34 per share.
Cash & Cash Equivalents | 633,000 |
Total Debt | 3.67M |
Net Cash | -3.04M |
Net Cash Per Share | -0.34 |
Equity (Book Value) | -61.44M |
Book Value Per Share | -6.83 |
Working Capital | -66.52M |
Cash Flow
Operating Cash Flow | -265,000 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 12.91%, with operating and profit margins of -13.49% and -30.25%.
Gross Margin | 12.91% |
Operating Margin | -13.49% |
Pretax Margin | -30.42% |
Profit Margin | -30.25% |
EBITDA Margin | -11.36% |
EBIT Margin | -13.49% |
FCF Margin | n/a |
Dividends & Yields
Krakchemia does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -143.47% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Krakchemia has an Altman Z-Score of -11.78. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -11.78 |
Piotroski F-Score | n/a |